Cargando…

Paradigm change to cost-effective predictive and preventive medicine: individual profiling of healthy vasospastic individuals for targeted prevention as the cost-effective personalised medicine

Detalles Bibliográficos
Autores principales:	Golubnitschaja, Olga, Yeghiazaryan, Kristina, Flammer, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125882/ http://dx.doi.org/10.1186/1878-5085-5-S1-A155

Ejemplares similares

Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs
por: Yeghiazaryan, Kristina, et al.
Publicado: (2010)

Innovative strategies for prediction and targeted prevention of glaucoma in healthy vasospastic individuals: context of neurodegenerative pathologies
por: Yeghiazaryan, Kristina, et al.
Publicado: (2014)

Vasospastic individuals demonstrate significant similarity to glaucoma patients as revealed by gene expression profiling in circulating leukocytes
por: Yeghiazaryan, Kristina, et al.
Publicado: (2009)

Individualised patient profile: clinical utility of Flammer syndrome phenotype and general lessons for predictive, preventive and personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2018)

Coincidence of cardiovascular disease and breast cancer in females: Multi-modal strategies by predictive, preventive and personalised medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

General Report & Recommendations in Predictive, Preventive and Personalised Medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine
por: Golubnitschaja, Olga, et al.
Publicado: (2012)

Chromium picolinate therapy in pre/diabetes care: recognition of individual risks and outcomes
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

10th Anniversary of the European Association for Predictive, Preventive and Personalised (3P) Medicine - EPMA World Congress Supplement 2020
por: Golubnitschaja, Olga, et al.
Publicado: (2020)

Editorial Letter: Promoting Predictive, Preventive and Personalised Medicine in global scale
por: Golubnitschaja, Olga
Publicado: (2010)

Predictive, preventive and personalised medicine for age-related macular degeneration
por: Hasler, Pascal W., et al.
Publicado: (2010)

Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible?
por: Golubnitschaja, Olga, et al.
Publicado: (2010)

Promoting predictive, preventive and personalised medicine: European event of global importance
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

European strategies in predictive, preventive and personalised medicine: highlights of the EPMA World Congress 2011
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Promoting predictive, preventive and personalised medicine in global scale: the EPMA World Congress 2011
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

The EPMA Journal introduces a new type of research article dedicated to predictive, preventive and personalised medicine
por: Golubnitschaja, Olga
Publicado: (2013)

Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?
por: Golubnitschaja, Olga, et al.
Publicado: (2013)

Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine
por: Torres Crigna, Adriana, et al.
Publicado: (2021)

Birth asphyxia as the major complication in newborns: moving towards improved individual outcomes by prediction, targeted prevention and tailored medical care
por: Golubnitschaja, Olga, et al.
Publicado: (2011)

Vision of the first EPMA center for predictive, preventive and personalized medicine in Europe
por: Kapalla, Marko, et al.
Publicado: (2014)

Global strategies for non-communicable disease in terms of predictive, preventive and personalised medicine
por: Iso, Hiroyasu, et al.
Publicado: (2014)

Preventive regimen of immunostimulants within personalised “3S” paradigm of anticancer drug testing
por: Moiseeva, Ekaterina
Publicado: (2014)

Opinion controversy to chromium picolinate therapy’s safety and efficacy: ignoring ‘anecdotes’ of case reports or recognising individual risks and new guidelines urgency to introduce innovation by predictive diagnostics?
por: Golubnitschaja, Olga, et al.
Publicado: (2012)

Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments
por: Yeghiazaryan, Kristina, et al.
Publicado: (2011)

Time for new guidelines in personalised healthcare: PPPM related legislation
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Sleep quality and COVID-19 outcomes: the evidence-based lessons in the framework of predictive, preventive and personalised (3P) medicine
por: Richter, Kneginja, et al.
Publicado: (2021)

Wrist actigraphic approach in primary, secondary and tertiary care based on the principles of predictive, preventive and personalised (3P) medicine
por: Acker, Jens, et al.
Publicado: (2021)

Education in predictive, preventive and personalised medicine
Publicado: (2011)

Time for new guidelines in advanced diabetes care: Paradigm change from delayed interventional approach to predictive, preventive & personalized medicine
por: Golubnitschaja, Olga
Publicado: (2010)

Personalised medicine in asthma: from curative to preventive medicine
por: Guilleminault, Laurent, et al.
Publicado: (2017)

“Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities
por: Golubnitschaja, Olga, et al.
Publicado: (2014)

Targeted preventive measures and advanced approaches in personalised treatment of glaucoma neuropathy
por: Mozaffarieh, Maneli, et al.
Publicado: (2010)

Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine — comprehensive effects of phytochemicals in primary, secondary and tertiary care
por: Mazurakova, Alena, et al.
Publicado: (2022)

Professional education in PPPM as the realistic platform for the medicine of the future: EPMA takes action
por: Golubnitschaja, Olga
Publicado: (2014)

Stroke care in West Bohemia – personalised medicine approach
por: Polivka, Jiri, et al.
Publicado: (2014)

Fremanezumab for migraine prevention: more effective, less costly
Publicado: (2020)

Metabolically Healthy Obesity (MHO)—New Research Directions for Personalised Medicine in Cardiovascular Prevention
por: Nilsson, Peter M., et al.
Publicado: (2020)

Digital Health in Focus of Predictive, Preventive and Personalised Medicine
por: Mszar, Reed
Publicado: (2021)

Challenges in breast cancer management and prevention
por: Debald, Manuel, et al.
Publicado: (2014)

Whole genome sequencing in the study of disease and application in personalised medicine
por: Kumarasuriyar, A
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0cig73o6rco35itag20shcdc9r